-
Tris Pharma and KYE Pharmaceuticals Announce Exclusive License Agreement
Post on 7/9/20
-
Capital Rx Establishes Scholarship at Howard University to Support Next Generation of Pharmacists
Post on 7/19/20
-
Corporate Update From NxGen Brands
Post on 7/9/20
-
MJH Life Sciences Acquires Pharmaceutical Commerce
Post on 7/9/20
-
Merck: Amazing Oncology Division, Underwhelming Dividend Opportunity
Post on 7/9/20
-
Voltron Therapeutics Retains Buenaventura Advisors
Post on 7/9/20
-
Here's Why Pfizer Fell 14% in June
Post on 7/9/20
-
Regeneron Lands a $450 Million "Warp Speed" Contract for Its Prospective COVID-19 Treatment
Post on 7/9/20
-
Johnson & Johnson: Excellent Company Tarnished By Scandal
Post on 7/8/20
-
Does Pfizer's COVID-19 Vaccine Make the Big Pharma Stock a Buy?
Post on 7/8/20
-
Gracie Square Psychiatrist Offers Advice for Front-Line Health Care Workers Coping with Pandemic’s Emotional and Psychological Impact
Post on 7/7/20
-
Bioasis Announces Stock Option Grants
Post on 7/7/20
-
Johnson & Johnson: Building Your Core
Post on 7/7/20
-
Tonix Pharmaceuticals Plans Massachusetts R&D Facility
Post on 7/7/20
-
Vor Biopharma Raises $110M In Series B
Post on 7/7/20
-
Chembio Diagnostics Awarded BARDA Contract for Development of DPP COVID-19 Point-of-Care Antigen System
Post on 7/6/20
-
Pacira BioSciences Proposes Offering of $300M Senior Notes
Post on 7/6/20
-
NAPA Expands Anesthesia Services to University of Maryland Capital Region Health
Post on 7/6/20
-
Bristol-Myers Squibb: Growth And Valuation Trump Other Concerns
Post on 7/6/20
-
Regeneron's Arthritis Drug Fails COVID-19 Trial
Post on 7/6/20
-
Ten Health Care Stocks to Purchase for a COVID-19 Healing
Post on 7/5/20
-
Merck Animal Health Completes Acquisition of U.S. Rights to SENTINEL Brand of Combination Parasiticides for Companion Animals
Post on 7/2/20
-
Better Buy: Eli Lilly vs. Johnson & Johnson
Post on 7/2/20
-
Pfizer and BioNTech Post Positive Trial Data for Their COVID-19 Vaccine
Post on 7/2/20
-
Akari Therapeutics Enters Into a Securities Purchase Agreement for up to $30M with Aspire Capital Fund
Post on 7/2/20
New York
